VASIRIVA 2.5 (Rivaroxaban film-coated Tablets 2.5 mg)

Manufacturer
Hetero Labs Limited(INDIA)

Registraction Number
MAL24096030AZ

Content:

• Active Ingredient: Rivaroxaban 2.5 mg
• Inactive Ingredients: Various excipients (binders, fillers, etc.)

• Prevent major atherothrombotic events (cardiovascular death, myocardial infarction, and stroke) in adult patients with coronary artery disease (CAD) and/or symptomatic peripheral artery disease (PAD) at high risk of ischemic events.
• Reduce the risk of blood clots in adults with acute coronary syndrome (a group of conditions that includes heart attack and unstable angina).

• Dosage: The recommended dose is 2.5 mg taken twice daily. The exact dose and duration of treatment should be determined by your doctor based on your condition and individual needs.
• Administration: Swallow the tablet whole with water. Do not crush or chew the tablet.
• Precautions: Inform your doctor if you have any allergies, liver or kidney problems, or if you are pregnant or planning to become pregnant. Avoid using if you have untreated bacterial infections or conditions that increase the risk of bleeding.
• Storage: Store at room temperature, away from moisture and heat.